The effect of molecular weight and β-1,6-linkages on priming of macrophage function in mice by (1,3)-β-D-glucan

被引:103
作者
Cleary, JA
Kelly, GE
Husband, AJ
机构
[1] Univ Sydney, Dept Vet Anat & Pathol, Sydney, NSW 2006, Australia
[2] Novogen Ltd, N Ryde, NSW, Australia
关键词
glucan; immunomodulation; macrophage activation; particulate; structure;
D O I
10.1046/j.1440-1711.1999.00848.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
1,3-beta-D-glucans (glucans) are structural elements in the cell walls of yeast and fungi with immunomodulatory properties, mediated through their ability to activate macrophages. This study assessed the activation of cells of the peritoneal cavity between 3 and 90 days after i.p. injection of particulate yeast glucan differing in molecular weight (MW) and degree of (1,6)-linkages. Female QS mice, 7-9 weeks of age, were injected i.p., with varying doses of low (< 5 x 10(5)), medium (1-2 x 10(6)) or high (> 3 x 10(6)) MW glucans, all with low (< 5%) beta-(1,6)-linkages, or high MW (> 3 x 10(6)) glucan with high 1,6-linkages (> 20%). All glucans induced a transient increase in the proportion of neutrophils and eosinophils and a reduction in mast cell numbers in the peritoneal cavity. Peritoneal macrophages showed an altered morphology, increased intracellular acid phosphatase, increased LPS-stimulated NO production and increased PMA-stimulated superoxide production. There were no significant changes in serum lysozyme levels. Most macrophage activities returned to control levels by 28 days post injection of 1,3-beta-D-glucan. There was a trend for higher MW or (1,6)-linked (1,3)-beta-D-glucans to be more stimulatory. It was concluded that particulate yeast (1,3)-beta-D-glucan is an effective stimulator of immune function, the efficiency of which may be influenced by the MW and degree of (1,6)-linkages.
引用
收藏
页码:395 / 403
页数:9
相关论文
共 36 条
[1]   STIMULATION OF HUMAN MONOCYTE BETA-GLUCAN RECEPTORS BY GLUCAN PARTICLES INDUCES PRODUCTION OF TNF-ALPHA AND IL-1-BETA [J].
ABEL, G ;
CZOP, JK .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (08) :1363-+
[2]  
ADACHI Y, 1994, BIOL PHARM BULL, V17, P1554, DOI 10.1248/bpb.17.1554
[3]  
ADACHI Y, 1990, CHEM PHARM BULL, V38, P988
[4]   RANDOMIZED PHASE I/II TRIAL OF A MACROPHAGE-SPECIFIC IMMUNOMODULATOR (PGG-GLUCAN) IN HIGH-RISK SURGICAL PATIENTS [J].
BABINEAU, TJ ;
MARCELLO, P ;
SWAILS, W ;
KENLER, A ;
BISTRIAN, B ;
FORSE, RA .
ANNALS OF SURGERY, 1994, 220 (05) :601-609
[5]   (1->3)-beta-D-glucans as biological response modifiers: A review of structure-functional activity relationships [J].
Bohn, JA ;
BeMiller, JN .
CARBOHYDRATE POLYMERS, 1995, 28 (01) :3-14
[6]  
BROWDER W, 1988, SURGERY, V104, P224
[7]  
BURGALETA C, 1978, J RETICULOENDOTH SOC, V23, P195
[8]   CANDIDA-ALBICANS STIMULATES ARACHIDONIC-ACID LIBERATION FROM ALVEOLAR MACROPHAGES THROUGH ALPHA-MANNAN AND BETA-GLUCAN CELL-WALL COMPONENTS [J].
CASTRO, M ;
RALSTON, NVC ;
MORGENTHALER, TI ;
ROHRBACH, MS ;
LIMPER, AH .
INFECTION AND IMMUNITY, 1994, 62 (08) :3138-3145
[9]  
Compton R, 1996, AM SURGEON, V62, P14
[10]  
CZOP JK, 1988, J IMMUNOL, V141, P3170